CIK 0001651308 · Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981209416
- Phone
- 41-616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $48,487,541
- in 9 filings, $47.8M under 10b5-1 plans
Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-10 | OYLER JOHN Chief Executive Officer | Sale | −4,913 | $246.11 | $1.2M | 700 |
| 2025-03-10 | OYLER JOHN Chief Executive Officer | Sale | −700 | $246.85 | $173K | 0 |
| 2025-03-10 | OYLER JOHN Chief Executive Officer | Option exercise · Share Option (Right to Buy) | −1,033,552 | 4,055,422 | ||
| 2025-03-07 | OYLER JOHN Chief Executive Officer | Option exercise | +708,747 | $0.50 | $354K | 5,600,803 |
| 2025-03-07 | OYLER JOHN Chief Executive Officer | Option exercise | +58,590 | $6.50 | $381K | 58,590 |
| 2025-03-07 | OYLER JOHN Chief Executive Officer | Sale | −1,400 | $246.03 | $344K | 57,190 |
| 2025-03-07 | OYLER JOHN Chief Executive Officer | Sale | −2,100 | $246.10 | $517K | 55,090 |
| 2025-03-07 | OYLER JOHN Chief Executive Officer | Sale | −1,190 | $246.69 | $294K | 53,900 |
| 2025-03-07 | OYLER JOHN Chief Executive Officer | Sale | −13,918 | $246.91 | $3.4M | 39,982 |
| 2025-03-07 | OYLER JOHN Chief Executive Officer | Sale | −7,600 | $247.99 | $1.9M | 32,382 |
| 2025-03-07 | OYLER JOHN Chief Executive Officer | Sale | −8,905 | $249.04 | $2.2M | 23,477 |
| 2025-03-07 | OYLER JOHN Chief Executive Officer | Sale | −12,578 | $249.97 | $3.1M | 10,899 |
| 2025-03-07 | OYLER JOHN Chief Executive Officer | Sale | −2,300 | $251.00 | $577K | 8,599 |
| 2025-03-07 | OYLER JOHN Chief Executive Officer | Sale | −3,299 | $252.24 | $832K | 5,300 |
| 2025-03-07 | OYLER JOHN Chief Executive Officer | Sale | −1,100 | $253.21 | $279K | 4,200 |
| 2025-03-07 | OYLER JOHN Chief Executive Officer | Sale | −1,300 | $254.10 | $330K | 2,900 |
| 2025-03-07 | OYLER JOHN Chief Executive Officer | Sale | −2,400 | $255.02 | $612K | 500 |
| 2025-03-07 | OYLER JOHN Chief Executive Officer | Sale | −500 | $256.10 | $128K | 0 |
| 2025-03-07 | OYLER JOHN Chief Executive Officer | Option exercise · Share Option (Right to Buy) | −1,470,417 | 5,088,974 | ||
| 2025-03-06 | OYLER JOHN Chief Executive Officer | Option exercise | +486,161 | $0.50 | $243K | 4,892,056 |
Page 29 of 71 · 1,406 trades